3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
44
Leukemia, Lymphocytic, Chronic, B-Cell
16
Myelodysplastic Syndromes
7
Leukemia, Biphenotypic, Acute
5
Burkitt Lymphoma
5
Waldenstrom Macroglobulinemia
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
3
Myeloproliferative Disorders
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Blast Crisis
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Hairy Cell
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
3
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Sirolimus
1
Rituximab
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Cyclosporins
1
Cyclosporine
1
Busulfan
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm
×
venetoclax
×
30 days
×
Clear all
No trials found.